<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2022</volume><submitter>Li YK</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The unbalance of mitophagy was closely related to hepatocellular carcinoma (HCC) progression. At present, it has not been uncovered about the influence of mitophagy genes on HCC prognosis and their potential pathogenesis.&lt;h4>Materials and methods&lt;/h4>The expression and clinical information of HCC in TCGA cohort were used to identify mitophagy differentially expressed genes (MDEGs) with prognostic value. The prognostic model of mitophagy genes was built and externally validated by LASSO regression in TCGA cohort and ICGC cohort, respectively. The function of the prognostic signature and its association with immune cell infiltration were explored. The profile of MDEGs was validated with 39 pairs HCC and paracarcinoma tissues by quantitative reverse transcription-PCR (qRT-P</pubmed_abstract><journal>Disease markers</journal><pagination>4835826</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9507775</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes.</pubmed_title><pmcid>PMC9507775</pmcid><pubmed_authors>Wang BG</pubmed_authors><pubmed_authors>Xu Q</pubmed_authors><pubmed_authors>Yan LR</pubmed_authors><pubmed_authors>Li YK</pubmed_authors><pubmed_authors>Jiang LY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes.</name><description>&lt;h4>Background&lt;/h4>The unbalance of mitophagy was closely related to hepatocellular carcinoma (HCC) progression. At present, it has not been uncovered about the influence of mitophagy genes on HCC prognosis and their potential pathogenesis.&lt;h4>Materials and methods&lt;/h4>The expression and clinical information of HCC in TCGA cohort were used to identify mitophagy differentially expressed genes (MDEGs) with prognostic value. The prognostic model of mitophagy genes was built and externally validated by LASSO regression in TCGA cohort and ICGC cohort, respectively. The function of the prognostic signature and its association with immune cell infiltration were explored. The profile of MDEGs was validated with 39 pairs HCC and paracarcinoma tissues by quantitative reverse transcription-PCR (qRT-P</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-21T14:27:50.426Z</modification><creation>2025-04-21T14:27:50.426Z</creation></dates><accession>S-EPMC9507775</accession><cross_references><pubmed>36157211</pubmed><doi>10.1155/2022/4835826</doi></cross_references></HashMap>